Aimée Donald

479 total citations
21 papers, 229 citations indexed

About

Aimée Donald is a scholar working on Physiology, Cell Biology and Molecular Biology. According to data from OpenAlex, Aimée Donald has authored 21 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 7 papers in Cell Biology and 6 papers in Molecular Biology. Recurrent topics in Aimée Donald's work include Lysosomal Storage Disorders Research (16 papers), Cellular transport and secretion (7 papers) and Glycosylation and Glycoproteins Research (4 papers). Aimée Donald is often cited by papers focused on Lysosomal Storage Disorders Research (16 papers), Cellular transport and secretion (7 papers) and Glycosylation and Glycoproteins Research (4 papers). Aimée Donald collaborates with scholars based in United Kingdom, United States and Sweden. Aimée Donald's co-authors include Kelly Moyes, Sherri J. Morris, Tim Coulson, Tim Clutton‐Brock, Byron J. T. Morgan, M. J. Ellis, James Livesey, Derralynn Hughes, Reena Sharma and Fritz J. Sedlazeck and has published in prestigious journals such as Neurology, International Journal of Molecular Sciences and CHEST Journal.

In The Last Decade

Aimée Donald

16 papers receiving 221 citations

Peers

Aimée Donald
Xiaofeng Wan China
Bernhard Kempter Germany
Nelson Dl United States
Masakatsu Fujinoki Japan
Brinley F. Furey United States
Brant Mittler United States
Deborah E. Newman United States
Ciarán A. Shaughnessy United States
Stephanie J. Smith Australia
Melanie Weigert United States
Xiaofeng Wan China
Aimée Donald
Citations per year, relative to Aimée Donald Aimée Donald (= 1×) peers Xiaofeng Wan

Countries citing papers authored by Aimée Donald

Since Specialization
Citations

This map shows the geographic impact of Aimée Donald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimée Donald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimée Donald more than expected).

Fields of papers citing papers by Aimée Donald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimée Donald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimée Donald. The network helps show where Aimée Donald may publish in the future.

Co-authorship network of co-authors of Aimée Donald

This figure shows the co-authorship network connecting the top 25 collaborators of Aimée Donald. A scholar is included among the top collaborators of Aimée Donald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimée Donald. Aimée Donald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donald, Aimée, et al.. (2025). Gene therapy in neuronopathic lysosomal storage disorders. European Journal of Paediatric Neurology. 57. 41–49.
2.
Patterson, Marc C., Uma Ramaswami, Aimée Donald, et al.. (2025). Disease-Modifying, Neuroprotective Effect of N-Acetyl- l -Leucine in Adult and Pediatric Patients With Niemann-Pick Disease Type C. Neurology. 105(1). e213589–e213589.
3.
Wallom, Kerri‐Lee, Aimée Donald, Simona D’Amore, et al.. (2025). Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes. Orphanet Journal of Rare Diseases. 20(1). 545–545.
4.
Donald, Aimée, Domingo González‐Lamuño, José María Lloreda García, et al.. (2025). 250 cases of “type 2 Gaucher disease”: A novel system of clinical categorisation and evidence of genotype: Phenotype correlation. Molecular Genetics and Metabolism. 145(2). 109124–109124.
5.
Donald, Aimée, Gary Kok Yew Chan, Bethany H. Brown, et al.. (2025). Chest-sited intraventricular access devices for cerliponase alfa infusion in Batten disease at a single tertiary United Kingdom pediatric center. Journal of Neurosurgery Pediatrics. 37(1). 87–94.
6.
Donald, Aimée, et al.. (2025). Gaucher disease type 3: Classification of the chronic neuronopathic variant informed by genotype in a phenotypically diverse cohort. Genetics in Medicine. 27(9). 101502–101502. 1 indexed citations
7.
Hughes, Derralynn, et al.. (2025). Secondary Mitochondrial Dysfunction in Gaucher Disease Type I, II and III—Review of the Experimental and Clinical Evidence. Genes. 16(11). 1269–1269. 1 indexed citations
8.
Ghosh, Arunabha, Bénédicte Héron, Aimée Donald, et al.. (2024). Safety and preliminary efficacy of LYS-GM101 gene therapy in patients with GM1 gangliosidosis: Results of a phase I/II open-label clinical trial. Molecular Genetics and Metabolism. 141(2). 107839–107839. 1 indexed citations
9.
Donald, Aimée, Ashok Vellodi, Timothy M. Cox, et al.. (2022). Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease. Orphanet Journal of Rare Diseases. 17(1). 234–234. 16 indexed citations
10.
Stępień, Karolina M., et al.. (2022). Secondary Mitochondrial Dysfunction as a Cause of Neurodegenerative Dysfunction in Lysosomal Storage Diseases and an Overview of Potential Therapies. International Journal of Molecular Sciences. 23(18). 10573–10573. 7 indexed citations
11.
McErlane, Flora, et al.. (2021). Wearable Technologies for Children with Chronic Illnesses: An Exploratory Approach. Therapeutic Innovation & Regulatory Science. 55(4). 799–806. 7 indexed citations
12.
Ramaswami, Uma, Eugen Mengel, Moeenaldeen AlSayed, et al.. (2021). Throwing a spotlight on under-recognized manifestations of Gaucher disease: Pulmonary involvement, lymphadenopathy and Gaucheroma. Molecular Genetics and Metabolism. 133(4). 335–344. 24 indexed citations
13.
Donald, Aimée, Chong Yew Tan, Anupam Chakrapani, et al.. (2020). Eye movement biomarkers allow for the definition of phenotypes in Gaucher Disease. Orphanet Journal of Rare Diseases. 15(1). 349–349. 10 indexed citations
14.
Donald, Aimée, et al.. (2019). Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease. Orphanet Journal of Rare Diseases. 14(1). 212–212. 8 indexed citations
15.
Sedlazeck, Fritz J., Marco Toffoli, Stephen Mullin, et al.. (2019). Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION. Molecular Genetics & Genomic Medicine. 7(3). e564–e564. 51 indexed citations
16.
Donald, Aimée & Simon Jones. (2018). Is it time to redefine what it means to have type 3 Gaucher disease?. Molecular Genetics and Metabolism. 123(2). S40–S40. 1 indexed citations
17.
18.
Moyes, Kelly, Tim Coulson, Byron J. T. Morgan, et al.. (2006). Cumulative reproduction and survival costs in female red deer. Oikos. 115(2). 241–252. 64 indexed citations
19.
Yao, Lawrence & Aimée Donald. (1989). Rounded Atelectasis Associated with End-stage Renal Disease. CHEST Journal. 96(2). 441–443. 3 indexed citations
20.
Ellis, M. J., James Livesey, & Aimée Donald. (1988). Circulating plasma cfactor-likeg immunoreactivity. Journal of Endocrinology. 117(2). 299–307. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofeng Wan Breakdown of academic impact, for papers by Bernhard Kempter Breakdown of academic impact, for papers by Nelson Dl Breakdown of academic impact, for papers by Masakatsu Fujinoki Breakdown of academic impact, for papers by Brinley F. Furey Breakdown of academic impact, for papers by Brant Mittler Breakdown of academic impact, for papers by Deborah E. Newman Breakdown of academic impact, for papers by Ciarán A. Shaughnessy Breakdown of academic impact, for papers by Stephanie J. Smith Breakdown of academic impact, for papers by Melanie Weigert
Rankless by CCL
2026